BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2008
View Archived Issues
Inspire initiates second phase III denufosol tetrasodium trial in cystic fibrosis
Read More
Cellegy enters definitive merger agreement with Adamis
Read More
Dara BioSciences and Point Therapeutics consummate merger
Read More
Altor signs agreement with Genentech for antibody-based tissue factor antagonists
Read More
Serotonin system involved in chronic L-DOPA wearing-off effect
Read More
Recent Amgen patent discloses new treatment for idiopathic pulmonary fibrosis
Read More
Results from Merck & Co. HIV vaccine reported at the CROI meeting
Read More
Sublingual route effective for influenza vaccine in mice
Read More
Robust immune responses with multiclade HIV-1 DNA plasmid vaccine in phase I/II studies
Read More
EMEA accepts for filing sanofi pasteur's MAA for seasonal influenza vaccine
Read More
Mesoblast reports positive results from clinical trial of adult stem cells in fracture healing
Read More
FDA issues special protocol assessment to Wilex for phase III trial of CA9-SCAN
Read More
Raven completes enrollment in phase I/IIa clinical trial of RAV-12 therapeutic antibody
Read More
Lipoxen and the Serum Institute of India initiate dosing in phase I trial of ErepoXen
Read More
Novel anti-HIV agents described in recent Merck patent
Read More
New therapeutic agents for HCV infection reported in recent patent literature
Read More
Bioniche presents update on Urocidin trial in refractory bladder cancer
Read More
FDA grants fast track status to Boehringer Ingelheim's BIBW-2992 for NSCLC
Read More
Qiagen and Center for Molecular Medicine research molecular diagnostic markers
Read More
YM Biosciences enrolls first patient in phase II nimotuzumab trial in brain cancer
Read More
Dainippon Sumitomo recaps Q3 developments
Read More